These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1018 related articles for article (PubMed ID: 18819934)

  • 81. Oestradiol regulation of the components of the plasminogen-plasmin system in MDA-MB-231 human breast cancer cells stably expressing the oestrogen receptor.
    Levenson AS; Kwaan HC; Svoboda KM; Weiss IM; Sakurai S; Jordan VC
    Br J Cancer; 1998 Jul; 78(1):88-95. PubMed ID: 9662256
    [TBL] [Abstract][Full Text] [Related]  

  • 82. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
    Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
    J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Plasminogen activator inhibitors regulate cell adhesion through a uPAR-dependent mechanism.
    Czekay RP; Loskutoff DJ
    J Cell Physiol; 2009 Sep; 220(3):655-63. PubMed ID: 19472211
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Sphingosine kinase 1 enhances colon cancer cell proliferation and invasion by upregulating the production of MMP-2/9 and uPA via MAPK pathways.
    Liu SQ; Huang JA; Qin MB; Su YJ; Lai MY; Jiang HX; Tang GD
    Int J Colorectal Dis; 2012 Dec; 27(12):1569-78. PubMed ID: 22684547
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Urokinase-type plasminogen activator, its inhibitor, and its receptor in patients with upper urinary tract carcinoma.
    Nakanishi K; Kawai T; Torikata C; Aurues T; Ikeda T
    Cancer; 1998 Feb; 82(4):724-32. PubMed ID: 9477106
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Expression of urokinase-type plasminogen activator (uPA), its receptor (uPAR), and inhibitor (PAI-1) in human breast carcinomas and their clinical relevance.
    Andres SA; Edwards AB; Wittliff JL
    J Clin Lab Anal; 2012 Feb; 26(2):93-103. PubMed ID: 22467324
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Expression of S1P metabolizing enzymes and receptors correlate with survival time and regulate cell migration in glioblastoma multiforme.
    Bien-Möller S; Lange S; Holm T; Böhm A; Paland H; Küpper J; Herzog S; Weitmann K; Havemann C; Vogelgesang S; Marx S; Hoffmann W; Schroeder HW; Rauch BH
    Oncotarget; 2016 Mar; 7(11):13031-46. PubMed ID: 26887055
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Nipple aspirate fluid expression of urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor predicts breast cancer diagnosis and advanced disease.
    Qin W; Zhu W; Wagner-Mann C; Sauter ER
    Ann Surg Oncol; 2003 Oct; 10(8):948-53. PubMed ID: 14527916
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Immunohistochemical localization of a urokinase-type plasminogen activator system in squamous cell carcinoma of the oral cavity: association with mode of invasion and lymph node metastasis.
    Nozaki S; Endo Y; Kawashiri S; Nakagawa K; Yamamoto E; Yonemura Y; Sasaki T
    Oral Oncol; 1998 Jan; 34(1):58-62. PubMed ID: 9659521
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression.
    Baker EA; Bergin FG; Leaper DJ
    Mol Pathol; 2000 Dec; 53(6):307-12. PubMed ID: 11193049
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The role of the urokinase-type plasminogen activator (uPA) and its receptor (CD87) in lipodermatosclerosis.
    Herouy Y; Aizpurua J; Stetter C; Dichmann S; Idzko M; Hofmann C; Gitsch G; Vanscheidt W; Schöpf E; Norgauer J
    J Cutan Pathol; 2001 Jul; 28(6):291-7. PubMed ID: 11401675
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Increased expression of urokinase plasminogen activator and its cognate receptor in human seminomas.
    Ulisse S; Baldini E; Mottolese M; Sentinelli S; Gargiulo P; Valentina B; Sorrenti S; Di Benedetto A; De Antoni E; D'Armiento M
    BMC Cancer; 2010 Apr; 10():151. PubMed ID: 20403162
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor.
    Olson D; Pöllänen J; Høyer-Hansen G; Rønne E; Sakaguchi K; Wun TC; Appella E; Danø K; Blasi F
    J Biol Chem; 1992 May; 267(13):9129-33. PubMed ID: 1315748
    [TBL] [Abstract][Full Text] [Related]  

  • 94. HDL3, but not HDL2, stimulates plasminogen activator inhibitor-1 release from adipocytes: the role of sphingosine-1-phosphate.
    Lee MH; Hammad SM; Semler AJ; Luttrell LM; Lopes-Virella MF; Klein RL
    J Lipid Res; 2010 Sep; 51(9):2619-28. PubMed ID: 20522601
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Nicotine stimulates urokinase-type plasminogen activator receptor expression and cell invasiveness through mitogen-activated protein kinase and reactive oxygen species signaling in ECV304 endothelial cells.
    Khoi PN; Park JS; Kim NH; Jung YD
    Toxicol Appl Pharmacol; 2012 Mar; 259(2):248-56. PubMed ID: 22261521
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Vitamin D3 modulation of plasminogen activator inhibitor type-1 in human breast carcinomas under organ culture.
    Barbosa EM; Nonogaki S; Katayama ML; Folgueira MA; Alves VF; Brentani MM
    Virchows Arch; 2004 Feb; 444(2):175-82. PubMed ID: 14652754
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A metabolic shift favoring sphingosine 1-phosphate at the expense of ceramide controls glioblastoma angiogenesis.
    Abuhusain HJ; Matin A; Qiao Q; Shen H; Kain N; Day BW; Stringer BW; Daniels B; Laaksonen MA; Teo C; McDonald KL; Don AS
    J Biol Chem; 2013 Dec; 288(52):37355-64. PubMed ID: 24265321
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity.
    Czekay RP; Kuemmel TA; Orlando RA; Farquhar MG
    Mol Biol Cell; 2001 May; 12(5):1467-79. PubMed ID: 11359936
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Urokinase-type plasminogen activator receptor is internalized by different mechanisms in polarized and nonpolarized Madin-Darby canine kidney epithelial cells.
    Vilhardt F; Nielsen M; Sandvig K; van Deurs B
    Mol Biol Cell; 1999 Jan; 10(1):179-95. PubMed ID: 9880335
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Photolysis of caged sphingosine-1-phosphate induces barrier enhancement and intracellular activation of lung endothelial cell signaling pathways.
    Usatyuk PV; He D; Bindokas V; Gorshkova IA; Berdyshev EV; Garcia JG; Natarajan V
    Am J Physiol Lung Cell Mol Physiol; 2011 Jun; 300(6):L840-50. PubMed ID: 21478254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.